Mr. Bjerkholt brings extensive business leadership experience across a broad range of roles and is currently Chief Financial Officer of Mirum Pharmaceuticals, Inc. He joined Mirum from Chinook Therapeutics, Inc. where he also served as CFO overseeing financial reporting, planning and budgeting, internal controls, investor relations, facilities, and information technology functions. Chinook was acquired by Novartis AG. Prior to Chinook, Mr. Bjerkholt was CFO of Aimmune Therapeutics, which was acquired by Nestle Health Science. Previously Mr. Bjerkholt worked at Sunesis Pharmaceuticals, Inc., where in addition to CFO, he served in various capacities, including Executive Vice President of Corporate Development and Finance, Corporate Secretary and Chief Compliance Officer. Mr.